Challenges to the FDA Approval of Mifepristone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges to the FDA Approval of Mifepristone

Published:2004-01 Issue:1 Volume:38 Page:163-168
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Calhoun Byron C¹,Harrison Donna J²

Affiliation:

1. Byron C Calhoun MD FACOG FACS, Division of Maternal-Fetal Medicine; Director, Antepartum Diagnostic Center, Rockford, IL

2. Donna J Harrison MD, Chairman, Subcommittee on Mifeprex, American Association of Pro Life Obstetricians and Gynecologists, Holland, MD

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1345/aph.1D448

Reference24 articles.

1. Effect of Chronic Treatment with the Glucocorticoid Antagonist RU 486 in Man: Toxicity, Immunological, and Hormonal Aspects

2. Clinical pharmacology of RU 486—an antiprogestin and antiglucocorticoid

3. Estrogen and progesterone receptors in human decidua after RU486* treatment†

4. Early Pregnancy Termination with Mifepristone and Misoprostol in the United States

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Notes;Abortion and the Law in America;2020-03-31

2. Mifepristone;Meyler's Side Effects of Drugs;2016

3. SEX HORMONES AND RELATED DRUGS;Meyler's Side Effects of Endocrine and Metabolic Drugs;2009

4. 40 Sex hormones and related compounds, including hormonal contraceptives;Side Effects of Drugs Annual;2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP